Ozempic and HCG: Exploring the Combination for Weight Loss

Last reviewed: July 3, 2026

Last updated: July 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide and other GLP-1 medications have demonstrated 15-22% weight loss in clinical trials, making them among the most effective pharmacological weight-loss tools available. However, combining GLP-1 drugs with human chorionic gonadotropin (HCG)—a hormone marketed in weight-loss protocols—lacks robust scientific support. Understanding what actually works helps you make informed decisions about your weight-loss strategy.

How GLP-1 Medications Work for Weight Loss

GLP-1 receptor agonists like semaglutide and tirzepatide function by slowing gastric emptying, increasing feelings of fullness, and signaling satiety to the brain. These medications target the glucagon-like peptide-1 receptor pathway, which naturally regulates hunger hormones and blood sugar. Clinical studies show that patients using semaglutide lose significantly more weight than those on lifestyle changes alone.

The mechanism is distinct from older weight-loss drugs because GLP-1 agonists mimic a hormone your body produces naturally after eating. This means they work with your physiology rather than forcing artificial appetite suppression. Most patients experience reduced cravings and smaller portion sizes without extreme dietary restriction, making adherence more sustainable over months and years.

Why HCG Combinations Lack Scientific Evidence

Human chorionic gonadotropin is a hormone produced during pregnancy, but its role in non-pregnant weight loss has never been validated in peer-reviewed trials. The FDA does not recognize HCG as safe or effective for weight loss, and any claims linking HCG to fat reduction remain anecdotal. Most weight loss attributed to HCG protocols comes from the extremely low calorie diet (typically 500 calories daily) that accompanies the hormone, not the hormone itself.

Additionally, very-low-calorie diets carry risks including muscle loss, nutritional deficiency, metabolic slowdown, and rebound weight gain. Combining an unproven hormone with an unsustainable diet strategy creates a foundation that contradicts modern weight-loss science. PlexusDx focuses instead on clinically validated GLP-1 compounds that produce lasting results without severe calorie restriction.

GLP-Squared: A Dual-Compound Alternative with Real Evidence

PlexusDx GLP-Squared combines semaglutide and tirzepatide—two FDA-studied GLP-1 and GIP receptor agonists—in a single injectable or oral formulation. Tirzepatide activates both the GLP-1 receptor and the glucose-dependent insulinotropic peptide (GIP) receptor, offering a broader hormonal target than semaglutide alone. This dual-pathway approach may enhance weight loss and improve metabolic outcomes in patients who plateau on single-agent therapy.

GLP-Squared Injection is $289/mo month-to-month (or $249/mo on the 3-month plan) from licensed 503A compounding pharmacies, with pricing flat across all dose levels—meaning your dose may increase without your monthly cost changing. Patients can begin with semaglutide monotherapy and graduate to the dual compound if needed, creating a personalized escalation pathway. No insurance is required, and all medications are HSA/FSA eligible, making evidence-based treatment accessible regardless of your coverage status.

Personalization Through Genetic Testing

PlexusDx Precision Peptide Genetic Test ($298) analyzes your genetic predispositions across 14 metabolic pathways and 49 peptides, including key variants like GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. These variants influence how your body responds to GLP-1 therapy, insulin signaling, and appetite regulation. Understanding your genetic profile helps PlexusDx clinicians optimize which compound, dose escalation path, and adjunct strategies work best for your unique physiology.

Genetic testing transforms weight loss from a one-size-fits-all approach into a precision strategy tailored to your metabolic wiring. Patients with certain GLP1R variants, for example, may benefit from earlier escalation to dual-compound therapy, while others optimize on semaglutide monotherapy. This data-driven personalization removes guesswork and accelerates your progress toward your weight-loss goals.

Safety, Side Effects, and Long-Term Sustainability

GLP-1 medications carry well-documented side effects during dose escalation, including nausea, constipation, and mild gastrointestinal upset. However, these effects typically resolve within days to weeks as your body adapts, and they are temporary and reversible—unlike the muscle loss and metabolic damage associated with extreme calorie restriction. PlexusDx clinicians guide gradual dose increases to minimize tolerability issues while maximizing weight-loss efficacy.

Long-term safety data for semaglutide and tirzepatide spans multiple years and thousands of patients, with cardiovascular and metabolic benefits documented in major trials. HCG protocols, by contrast, carry risks that intensify with duration: electrolyte imbalance, thyroid suppression, and severe rebound weight gain upon discontinuation. Choosing a clinically proven GLP-1 strategy protects both your short-term comfort and your long-term metabolic health.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The GLP-Squared is $289/mo month-to-month, or from $249/mo on the 3-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is the combination of GLP-1 and HCG safe?

No clinical evidence supports HCG for weight loss, and the FDA has not approved it for this use. GLP-1 medications alone have robust safety data across thousands of patients. PlexusDx recommends evidence-based GLP-1 therapy, including GLP-Squared dual compounds, over unproven hormone combinations.

How much weight can I lose with semaglutide or tirzepatide?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

What does GLP-Squared cost, and does the price change with my dose?

GLP-Squared Injection is $289/mo month-to-month (or $249/mo on the 3-month plan), with pricing flat across all dose levels. Your dose may increase as needed—your price won't. All PlexusDx medications are HSA/FSA eligible and available in all 50 states without insurance.

Are PlexusDx medications FDA-approved?

PlexusDx semaglutide and tirzepatide are compounded by licensed 503A pharmacies and contain the same active ingredients studied and approved by the FDA. Compounded versions provide the same clinical efficacy at significantly lower cost than brand-name equivalents.

How can genetic testing improve my weight-loss results?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.